Factors influencing participation in educational workshops as part of a pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease: a retrospective study.


Journal

Expert review of respiratory medicine
ISSN: 1747-6356
Titre abrégé: Expert Rev Respir Med
Pays: England
ID NLM: 101278196

Informations de publication

Date de publication:
03 2022
Historique:
pubmed: 9 10 2021
medline: 7 4 2022
entrez: 8 10 2021
Statut: ppublish

Résumé

Pulmonary rehabilitation (PR) (primarily composed of an exercise training program (ET) and educational workshops) is an effective intervention for patients with chronic obstructive pulmonary disease. Although factors which influence participation in the full PR program have been reported, specific data on the educational component of PR have not been published. We aimed to identify factors which predict refusal to participate in the educational component of PR. 201 patient charts were retrospectively included in the analysis. Patients were classified according to their acceptance or refusal to participate in the educational workshops. The location of ET outside the center was independently related to refusal to participate in the educational workshops (OR = 0.01 [95%CI 0.00 to 0.17]). Patients who refused the workshops were less disabled according to the number of prescriptions of noninvasive ventilation, use of medical transport, oxygen consumption and workload achieved during cardiopulmonary exercise testing. The location of exercise sessions during PR influences patients' decisions to refuse or accept center-based educational workshops. When center-based PR programs are limited, and the ET is relocated to the patient's home, the educational workshops should also be relocated. The trial is registered at ClinicalTrials.gov (NCT04301245).

Sections du résumé

BACKGROUND
Pulmonary rehabilitation (PR) (primarily composed of an exercise training program (ET) and educational workshops) is an effective intervention for patients with chronic obstructive pulmonary disease. Although factors which influence participation in the full PR program have been reported, specific data on the educational component of PR have not been published. We aimed to identify factors which predict refusal to participate in the educational component of PR.
RESEARCH DESIGN AND METHODS
201 patient charts were retrospectively included in the analysis. Patients were classified according to their acceptance or refusal to participate in the educational workshops.
RESULTS
The location of ET outside the center was independently related to refusal to participate in the educational workshops (OR = 0.01 [95%CI 0.00 to 0.17]). Patients who refused the workshops were less disabled according to the number of prescriptions of noninvasive ventilation, use of medical transport, oxygen consumption and workload achieved during cardiopulmonary exercise testing.
CONCLUSIONS
The location of exercise sessions during PR influences patients' decisions to refuse or accept center-based educational workshops. When center-based PR programs are limited, and the ET is relocated to the patient's home, the educational workshops should also be relocated.
TRIAL REGISTRATION
The trial is registered at ClinicalTrials.gov (NCT04301245).

Identifiants

pubmed: 34623218
doi: 10.1080/17476348.2022.1991793
doi:

Banques de données

ClinicalTrials.gov
['NCT04301245']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

341-349

Auteurs

Pauline Smondack (P)

ADIR Association, Rouen University Hospital, Rouen, France.

Francis-Edouard Gravier (FE)

ADIR Association, Rouen University Hospital, Rouen, France.
Normandie University, Unirouen, UPRES EA 3830, Rouen University Hospital, Haute-Normandie Research and Biomedical Innovation, Rouen, France.

Yann Combret (Y)

Physiotherapy Department, Le Havre Hospital, F-76600, Le Havre, France.

Jean-François Muir (JF)

ADIR Association, Rouen University Hospital, Rouen, France.
Normandie University, Unirouen, UPRES EA 3830, Rouen University Hospital, Haute-Normandie Research and Biomedical Innovation, Rouen, France.
Pulmonary, Thoracic Oncology and Respiratory Intensive Care Department, Rouen University Hospital, Rouen, France.

Antoine Cuvelier (A)

Normandie University, Unirouen, UPRES EA 3830, Rouen University Hospital, Haute-Normandie Research and Biomedical Innovation, Rouen, France.
Pulmonary, Thoracic Oncology and Respiratory Intensive Care Department, Rouen University Hospital, Rouen, France.

David Debeaumont (D)

Department of Respiratory and Exercise Physiology and CIC-CRB 1404, Rouen University Hospital, Rouen, France.

Clément Medrinal (C)

Intensive Care Unit Department, Le Havre Hospital, Le Havre, France.
UR 20201 ERPHAN, Université Paris-Saclay, UVSQ, Versailles, France.
IFMK Saint Michel, Paris, France.

Guillaume Prieur (G)

Normandie University, Unirouen, UPRES EA 3830, Rouen University Hospital, Haute-Normandie Research and Biomedical Innovation, Rouen, France.
Intensive Care Unit Department, Le Havre Hospital, Le Havre, France.

Tristan Bonnevie (T)

ADIR Association, Rouen University Hospital, Rouen, France.
Normandie University, Unirouen, UPRES EA 3830, Rouen University Hospital, Haute-Normandie Research and Biomedical Innovation, Rouen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH